Please assess the completion status of the following clinical trial:

Trial Title: A Novel Device for the Management of ADHD

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Documented history of primary ADHD diagnosis by certified clinicians~* Age 18-40 y~* Written informed consent~* Able and willing to complete all required ratings and assessments~Exclusion criteria:~* Any current psychiatric / neurological comorbidity (e.g., epilepsy, Autism, depression, TBI, etc), other than ADHD~* ADHD Medications (stimulants, non-stimulants, other)~* Neurofeedback, cognitive training

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Active (Type: EXPERIMENTAL): VIZO Glasses- personalized

Based on this trial design, predict the completion outcome and termination type (if applicable).